Phase 2 trial results with the novel neurokinin-1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving moderately emetogenic chem (Q43260275)
Jump to navigation
Jump to search
scientific article published in December 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 2 trial results with the novel neurokinin-1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving moderately emetogenic chem |
scientific article published in December 2009 |
Statements
1 reference
Phase 2 trial results with the novel neurokinin-1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving moderately emetogenic chem (English)
1 reference
Wichit Arpornwirat
1 reference
Istvan Albert
1 reference
Vincent L Hansen
1 reference
Jeremey Levin
1 reference
Rajesh R Bandekar
1 reference
Steven M Grunberg
1 reference
1 December 2009
1 reference
1 reference
115
1 reference
24
1 reference
5807-5816
1 reference
Identifiers
1 reference
1 reference